A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

Podobne zapisy

• THROMBOTIC THROMBOCYTOPENIC PURPURA
  od: Ali Rıza Odabaş, i wsp.
  Wydane: (2019-09-01)
• Vaccination and Thrombotic Thrombocytopenic Purpura
  od: İrfan Yavaşoğlu
  Wydane: (2020-08-01)
• Thrombotic thrombocytopenic purpura: much done, but still a lot to do
  od: Paola Binetti
  Wydane: (2024-08-01)
• A Case of Acquired Thrombotic Thrombocytopenic Purpura: Three Recurrences in 25 Years
  od: Şinasi Özsoylu
  Wydane: (2015-07-01)
• Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura
  od: Alev Akyol Erikçi, i wsp.
  Wydane: (2016-05-01)